Moffitt Study Reveals New Mechanism of Drug Resistance in Melanoma Leptomeningeal Disease
Leptomeningeal disease is a rare but lethal complication faced by late-stage melanoma patients. It occurs when cancer cells spread to the membranes covering the brain and spinal cord, or the leptomeninges. This condition, which affects 5% to 8% of...
11-Jun-2024 11:05 AM EDT
Add to Favorites